[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"in-stent-restenosis-lesion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:in-stent-restenosis-lesion":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100591547","sirolimus-with-corticosteroid-therapy-for-rapid-recurrences-of-coronary-unexplained-in-stent-restenosis-100591547",false,"NCT06981845","Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis","Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis (STOP-RECUR) Study","STOP-RECUR","Inclusion Criteria:\n\n1. Age ≥ 18 years old\n2. Able to understand the trial design and sign an informed consent form\n3. Patients meeting the RECUR definition\n4. Satisfactory results from revascularization within the past two weeks\n5. Receiving standard secondary prevention medication for coronary heart disease with treatment targets achieved\n\nExclusion Criteria:\n\nPregnant women, individuals known to be allergic to the study drug, those currently participating in other interventional clinical trials, or participants deemed unsuitable for this study based on the investigator's judgment.","ALL","18 Years",{"count":20,"type":21},52,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to evaluate, through a multicenter, prospective, double-blind, randomized, placebo-controlled clinical trial, whether immunosuppressive therapy improves target lesion-related cardiovascular outcomes compared to placebo treatment in patients with Rapid rEcurrence of Coronary Unexplained in-stent Restenosis (RECUR).",[27,28],"In-stent Restenosis Lesion","Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))","NOT_YET_RECRUITING","2025-05-13",{"date":32,"type":33},"2025-05-21","ACTUAL",{"date":35,"type":21},"2025-06-01",{"date":37,"type":21},"2028-06-01",{"name":39,"class":40},"China National Center for Cardiovascular Diseases","OTHER_GOV"]